1. Zafirlukast
2. Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal-phase high-performance liquid chromatography with fluorescence detection
3. S.B. French, K.H. Bui, ZENECA Pharmaceuticals, unpublished results.
4. W. Nemrod, D. Mathieu, J. Nony, R. Phan-Tan-Luu, LPRAI SARL, Marseilles, F-13331, France.
5. Topic Q2B, Validation of Analytical Methods: Methodology: The Third International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH3, Yokohama, Japan, 29 November–1 December, 1995.